BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4044029)

  • 1. Sensitivity of Capnocytophaga species to bactericidal properties of human serum.
    Wilson ME; Burstein R; Jonak-Urbanczyk JT; Genco RJ
    Infect Immun; 1985 Oct; 50(1):123-9. PubMed ID: 4044029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capnocytophaga species: increased resistance of clinical isolates to serum bactericidal action.
    Wilson ME; Jonak-Urbanczyk JT; Bronson PM; Dudas KC; Apicella MA; Genco RJ
    J Infect Dis; 1987 Jul; 156(1):99-106. PubMed ID: 3598230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and partial characterization of a genus common antigen and species specific antigen of Capnocytophaga.
    Murayama Y; Mashimo PA; Tabak LA; Levine MJ; Ellison SA
    Jpn J Med Sci Biol; 1982 Aug; 35(4):153-70. PubMed ID: 6185710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.
    Miyasaki KT; Bodeau AL; Ganz T; Selsted ME; Lehrer RI
    Infect Immun; 1990 Dec; 58(12):3934-40. PubMed ID: 2254020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human complement activation by purified Capnocytophaga exopolysaccharide. Measurement by radioimmunoassay.
    Bolton RW; Dyer JK
    J Periodontal Res; 1986 Nov; 21(6):634-9. PubMed ID: 2947996
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum antibody responses in human periodontitis to cellular components of Capnocytophaga.
    Dyer JK; Reinhardt RA; Petro TM; Strom EA
    Arch Oral Biol; 1992 Sep; 37(9):725-31. PubMed ID: 1417521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-D types and serum IgG responses to Capnocytophaga in diabetes and periodontitis.
    Dyer JK; Peck MA; Reinhardt RA; Duckworth WC; Booth SJ; Seymour GJ; Patil KD
    J Dent Res; 1997 Dec; 76(12):1825-32. PubMed ID: 9390475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization.
    Socransky SS; Holt SC; Leadbetter ER; Tanner AC; Savitt E; Hammond BF
    Arch Microbiol; 1979 Jul; 122(1):29-33. PubMed ID: 518236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity.
    Miyasaki KT; Bodeau AL
    J Clin Invest; 1991 May; 87(5):1585-93. PubMed ID: 2022730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil cathepsin G and elastase.
    Miyasaki KT; Bodeau AL
    Infect Immun; 1991 Sep; 59(9):3015-20. PubMed ID: 1879926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of lectinlike surface components on Capnocytophaga ochracea ATCC 33596 that mediate coaggregation with gram-positive oral bacteria.
    Weiss EI; London J; Kolenbrander PE; Kagermeier AS; Andersen RN
    Infect Immun; 1987 May; 55(5):1198-202. PubMed ID: 3570460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid killing of Capnocytophaga canimorsus and Capnocytophaga cynodegmi by human whole blood and serum is mediated via the complement system.
    Zangenah S; Bergman P
    Springerplus; 2015; 4():517. PubMed ID: 26405637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.
    Miyasaki KT; Bodeau AL
    Infect Immun; 1992 Nov; 60(11):4973-5. PubMed ID: 1399008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic relationships and species differentiation in the genus Capnocytophaga.
    Speck H; Kroppenstedt RM; Mannheim W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):390-402. PubMed ID: 3439382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human Capnocytophaga species by multilocus enzyme electrophoretic analysis and serotyping of immunoglobulin A1 proteases.
    Frandsen EVG; Wade WG
    Microbiology (Reading); 1996 Feb; 142 ( Pt 2)():441-448. PubMed ID: 8932716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing of oral, gram-negative, facultative bacteria by the rabbit defensin, NP-1.
    Miyasaki KT; Bodeau AL; Selsted ME; Ganz T; Lehrer RI
    Oral Microbiol Immunol; 1990 Dec; 5(6):315-9. PubMed ID: 2098709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic and antigenic characterization of immunoglobulin A1 proteases from Bacteroides and Capnocytophaga spp.
    Frandsen EV; Reinholdt J; Kilian M
    Infect Immun; 1987 Mar; 55(3):631-8. PubMed ID: 3546133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil granule components.
    Miyasaki KT; Bodeau AL; Flemmig TF
    Infect Immun; 1991 Oct; 59(10):3760-7. PubMed ID: 1894375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.